SEELOS THERAPEUTICS INC (SEEL)

US81577F3073 - Common Stock

1.33  -0.04 (-2.92%)

After market: 1.34 +0.01 (+0.75%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

 MRQ
(2024-3-31)		 2023
(2023-12-31)		 2022
(2022-12-31)		 2021
(2021-12-31)		 2020
(2020-12-31)
ASSETS
Current Assets
Cash
524.00K3.00M15.53M78.73M15.66M
Cash Equivalents
N/AN/AN/AN/AN/A
Receivables
968.00K763.00KN/AN/AN/A
Inventories
N/AN/AN/AN/AN/A
Other Current Assets
2.06M1.64M7.14M4.73M1.83M
Total Current Assets
3.55M5.40M22.67M83.46M17.49M
 
Non-Current Assets
PPE Net
62.00K15.00K70.00K40.00KN/A
Other Non-Current Assets
N/AN/AN/AN/AN/A
Total Non-Current Assets
62.00K15.00K80.00K40.00K0.00
 
TOTAL ASSETS
3.61M5.42M22.75M83.50M17.49M
 
LIABILITIES
Current Liabilities
Short Term Debt
0.000.000.000.000.00
Current Portion Of LT Debt.
13.07M14.21M11.87M1.03M2.43M
Accrued Expenses
4.59M2.53M7.34M3.77M1.92M
Accounts Payable
15.27M16.40M3.63M1.69M1.89M
Other Current Liabilities
3.79M5.78M2.33M1.80M1.19M
Total Current Liabilities
36.72M38.93M25.16M8.29M7.43M
 
Non-Current Liabilities
Long Term Debt
0.000.008.18M17.89M7.29M
Other Non-Current Liabilities
N/AN/A20.00K0.00200.00K
Total Non-Current Liabilities
0.000.008.20M17.89M7.49M
 
TOTAL LIABILITIES
36.72M38.93M33.36M26.18M14.92M
 
SHAREHOLDERS' EQUITY
Retained Earnings
-255.29M-252.63M-214.74M-141.21M-75.16M
Additional Paid In Capital
222.17M219.11M204.03M198.43M77.68M
Common Shares
15.00K10.00K110.00K110.00K50.00K
Shares Outstanding
1.91M1.22M107.17M105.50M54.54M
Tangible Book Value per Share
-17.36-27.37-0.100.540.05
Total Shareholders' Equity
-33.10M-33.51M-10.61M57.32M2.57M
 
TOTAL LIABILITIES AND EQUITY
3.61M5.42M22.75M83.50M17.49M
 
Statistics
Debt/Equity
N/AN/A-0.770.312.84
Current Ratio
0.100.140.9010.072.35
Return On Assets (ROA)
-750.75%-699.19%-323.21%-79.10%-109.21%
Return On Equity (ROE)
N/AN/AN/A-115.23%-743.19%

All data in USD

Charts